Diedrich
Christian Diedrich, Dusseldorf DE
Patent application number | Description | Published |
---|---|---|
20120237856 | SELECTION METHOD FOR ADDITIVES IN PHOTOPOLYMERS - The invention relates to a method for selecting compounds which can be used as additives in photopolymer formulations for producing light holographic media, and to photopolymer formulations which contain at least one softener which are selected according to the claimed method. The invention also relates to the use of photopolymer formulations for producing holographic media. | 09-20-2012 |
Falko Diedrich, Munich DE
Patent application number | Description | Published |
---|---|---|
20120130098 | Skin Treatments Containing Carboxylic Acid-Substituted Idebenone Derivatives and Methods of Preparation and Use Thereof - The present invention relates to novel carboxylic acid-substituted idebenone derivatives, skin treatment compositions containing these carboxylic acid-substituted idebenone derivatives, methods of treating skin changes by topical application of these carboxylic acid-substituted idebenone derivatives, and their methods of synthesis. The carboxylic acid-substituted idebenone derivatives of the present invention are unexpectedly effective in treating skin, particularly with respect to skin tolerance. When included in a topical composition, the carboxylic acid-substituted idebenone derivatives of the present invention have an antioxidant effect that is useful in treating a skin change. | 05-24-2012 |
Falko Diedrich, Muenchen DE
Patent application number | Description | Published |
---|---|---|
20100086494 | SKIN TREATMENTS CONTAINING CARBOXYLIC ACID-SUBSTITUTED IDEBENONE DERIVATIVES AND METHODS OF PREPARATION AND USE THEREOF - The present invention relates to novel carboxylic acid-substituted idebenone derivatives, skin treatment compositions containing these carboxylic acid-substituted idebenone derivatives, methods of treating skin changes by topical application of these carboxylic acid-substituted idebenone derivatives, and their methods of synthesis. The carboxylic acid-substituted idebenone derivatives of the present invention are unexpectedly effective in treating skin, particularly with respect to skin tolerance. When included in a topical composition, the carboxylic acid-substituted idebenone derivatives of the present invention have an antioxidant effect that is useful in treating a skin change. | 04-08-2010 |
Falko Diedrich, Kaufungen DE
Patent application number | Description | Published |
---|---|---|
20130101534 | SKIN TREATMENTS CONTAINING CARBOXYLIC ACID-SUBSTITUTED IDEBENONE DERlVATIVES AND METHODS OF PREPARATION AND USE THEREOF - The present invention relates to novel carboxylic acid-substituted idebenone derivatives, skin treatment compositions containing these carboxylic acid-substituted derivatives, methods of treating skin changes by topical application of these carboxylic acid-substituted idebenone derivatives, and their methods of synthesis. The carboxylic acid-substituted idebenone derivatives of the present invention are unexpectedly effective in treating skin, particularly with respect to skin tolerance. When included in a topical composition, the carboxylic acid-substituted idebenone derivatives of the present invention have an antioxidant effect that is useful in treating a skin change. | 04-25-2013 |
Frank Diedrich, Tienen BE
Patent application number | Description | Published |
---|---|---|
20110126373 | WIPER BLADE WITH A SUPPORTING ELEMENT - The invention is based on a wiper blade ( | 06-02-2011 |
Georg Diedrich, Koln DE
Patent application number | Description | Published |
---|---|---|
20100087162 | Intelligent network for administrating premium rate calls - The invention relates to an Intelligent Network arranged to communicate with a mobile switching center of a mobile communication network. The Intelligent Network is arranged to receive a call message from said mobile switching center comprising a calling party number and a called party number; retrieve a routing label and a tariff cluster number from a first database using said called party number; modify said called party number by adding said routing label and said tariff cluster number as a prefix to said called party number to render a modified called party number; send a routing message to said mobile switching center comprising said modified called party number. | 04-08-2010 |
Klaus Diedrich, Grostrasse-Sarau DE
Patent application number | Description | Published |
---|---|---|
20110306547 | LHRH - ANTAGONISTS IN THE TREATMENT OF FERTILITY DISORDERS - A method of treating infertility disorders by 1) administering an LH-RH antagonist, preferably Cetrorelix, in amounts to selectively suppress endogenous LH but not FSH secretion and 2) inducing follicle growth by administration of exogenous gonadotropin. The selective suppression OF LH allows FSH secretion to be at natural level S thereby not affecting individual estrogen development. The LH-RH antagonist can be given as a single or dual subcutaneous dose in the range of 1 mg to 10 mg, preferably 2 mg-6 mg. In multiple dosing posology, LH-RH antagonist can be administered subcutaneously in an amount in the range of 0.1 to 0.5 mg of LH-RH antagonist/day . LH-RH antagonist is applied starting cycle day 1 to 10, preferably on day 4 to 8, and ovulation can be induced between day 9 and 20 of the menstruation cycle by administering rec. LH, native LH-RH, LH-RH agonist or by HCG. In addition rec. LH, native LH-RH or LH-RH agonist can be given to avoid hyperstimulation syndrome and native LH-RH or a LH-RH agonist can be administered to avoid luteal phase stimulation by neutralising the negative effects of HCG. | 12-15-2011 |
Klaus Diedrich, Gross-Sarau DE
Patent application number | Description | Published |
---|---|---|
20080255053 | METHOD FOR THE THERAPEUTIC MANAGEMENT OF ENDOMETRIOSIS - The present inventions provides a method for therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction by short term induction treatment with an LH-RH antagonist for 4 to 12 weeks. According to another aspect of the present invention, the short term LH-RH treatment is followed by the combined or separate administration of one or more active agents selected from the group consisting of a contraceptive, preferably an oral contraceptive, a non-steroidal anti-rheumatic agent, an analgetic, an androgen other than a 17-alpha-alkyl substituted testosterone or any combinations thereof. According to a further aspect of the present invention a pharmaceutical composition comprising an LHRH antagonist and one ore more active agents selected from the group consisting of a contraceptive, preferably an oral contraceptive, a non-steroidal anti-rheumatic agent, an analgetic, an androgen other than a 17-alpha-alkyl substituted testosterone or any combinations thereof are provided. | 10-16-2008 |
Thomas Diedrich, Gerwisch DE
Patent application number | Description | Published |
---|---|---|
20100316923 | FUEL CELL SYSTEM - The invention relates to a fuel cell stack ( | 12-16-2010 |